EZH2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.494400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.433400E-01
Normal-vs-Stage2
8.855400E-01
Normal-vs-Stage3
4.377600E-01
Normal-vs-Stage4
4.638800E-01
Stage1-vs-Stage2
2.510200E-01
Stage1-vs-Stage3
9.455800E-01
Stage1-vs-Stage4
8.916000E-01
Stage2-vs-Stage3
3.110800E-01
Stage2-vs-Stage4
2.742200E-01
Stage3-vs-Stage4
9.379400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.707600E-01
Normal-vs-AfricanAmerican
6.275000E-01
Normal-vs-Asian
8.158000E-01
Caucasian-vs-AfricanAmerican
6.329400E-01
Caucasian-vs-Asian
9.328600E-01
AfricanAmerican-vs-Asian
6.179600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.571800E-01
Normal-vs-Female
8.556600E-01
Male-vs-Female
4.539600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.209200E-01
Normal-vs-Age(41-60Yrs)
9.064400E-01
Normal-vs-Age(61-80Yrs)
6.837000E-01
Normal-vs-Age(81-100Yrs)
8.515600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.159800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.926050E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.008980E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.304000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.465000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.703600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.772000E-01
Normal-vs-Daily Drinker
7.869600E-01
Normal-vs-Weekly Drinker
7.797600E-01
Normal-vs-Occasional Drinker
4.372000E-01
Normal-vs-Social Drinker
9.596200E-01
Non Drinker-vs-Daily Drinker
9.074000E-01
Non Drinker-vs-Weekly Drinker
3.559400E-01
Non Drinker-vs-Occasional Drinker
4.655600E-01
Non Drinker-vs-Social Drinker
6.428400E-01
Daily Drinker-vs-Weekly Drinker
3.824400E-01
Daily Drinker-vs-Occasional Drinker
3.507800E-01
Daily Drinker-vs-Social Drinker
6.949800E-01
Weekly Drinker-vs-Occasional Drinker
1.959220E-01
Weekly Drinker-vs-Social Drinker
5.265800E-01
Occasional Drinker-vs-Social Drinker
2.284000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.077000E-01
Normal-vs-Grade 2
6.709800E-01
Normal-vs-Grade 3
6.751800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.858700E-03
Grade 1-vs-Grade 3
3.695500E-03
Grade 1-vs-Grade 4
6.077000E-01
Grade 2-vs-Grade 3
8.380200E-01
Grade 2-vs-Grade 4
6.709800E-01
Grade 3-vs-Grade 4
6.751800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.575400E-01
Normal-vs-NonDiabetic
8.204200E-01
Diabetic-vs-NonDiabetic
3.339600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.616800E-01
Normal-vs-NoPancreatitis
6.941600E-01
Pancreatitis-vs-NoPancreatitis
1.732440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.135200E-01
Normal-vs-N1
8.130800E-01
N0-vs-N1
7.269600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.989000E-01
Normal-vs-TP53-NonMutant
7.137600E-01
TP53-Mutant-vs-TP53-NonMutant
2.256800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
